llm_output,best_matching_ground_truth,best_evaluation,best_score
venlafaxine comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is accurate in identifying venlafaxine as comparable to tricyclic antidepressants (TCAs), but it does not mention monoamine oxidase inhibitors, which are also stated to have the same efficacy as TCAs in the Ground Truth.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder (mdd),Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is only partially correct as it mentions SSRIs as a first-line treatment for major depressive disorder, but does not accurately reflect the ground truth statement about Norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.5
mirtazapine properties increases serotonin or norepinephrine availability,Mirtazapine Increases Availability of serotonin or norepinephrine (or both),"Score: 0.90
The LLM output is almost identical to the Ground Truth statement, only slightly rearranged.",0.9
selective serotonin reuptake inhibitors (ssris) definition antidepressants that block serotonin reuptake,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is partially correct, as it mentions SSRI instead of Norepinephrine reuptake inhibitors, which are two different classes of antidepressants.",0.5
vortioxetine specific efficacy in treating depression-related cognitive impairment,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is somewhat related to the ground truth as it also involves treating depressive symptoms, but it is not directly addressing the specific purposes mentioned in the ground truth statement.",0.5
selective serotonin reuptake inhibitors (ssris) comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.80
The LLM output is mostly correct as it correctly identifies the comparison between ssris and tcas, but it misidentifies ssris as the class of antidepressants instead of maois.",0.8
mirtazapine side effects weight gain,"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.50
The LLM output is off-topic and not related to the ground truth, resulting in a lower correctness score.",0.5
monoamine oxidase inhibitors (maois) less commonly used depression treatment,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly identifies monoamine oxidase inhibitors as a type of depression treatment, but inaccurately states that they are less commonly used.",0.75
selective serotonin reuptake inhibitors (ssris) side effects sexual dysfunction,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The output is only partially correct, as it mentions side effects but not specific to monoamine oxidase inhibitors, and does not mention hepatotoxicity or hypertensive crises.",0.5
ketamine definition treatment for resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct in identifying ketamine as a treatment for resistant depression, but lacks specificity regarding its effects on unipolar and bipolar depression.",0.75
esketamine associated with risk of substance abuse,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output discusses a potential risk associated with esketamine, which is unrelated to the ground truth statement about marital and family therapy for treating severe forms of depression.",0.5
"ketamine side effects neurotoxicity, drug dependence",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The LLM output is only partially correct as it does not properly address the ground truth statement about monoamine oxidase inhibitors and their side effects.",0.5
monoamine oxidase inhibitors (maois) specific efficacy in treating depression with atypical features,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is fairly close to the ground truth but includes additional information about the specific efficacy of monoamine oxidase inhibitors in treating depression with atypical features.",0.75
electroconvulsive therapy (ect) highly effective somatic therapy for depression,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The LLM output is somewhat correct in identifying a therapy for depression, but there is a discrepancy in the type of therapy mentioned.",0.75
cognitive-behavioral therapy (cbt) first-line treatment major depressive disorder (mdd),"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output correctly identifies cognitive-behavioral therapy (CBT) as a first-line treatment for major depressive disorder (MDD) but does not mention the other therapies typically included in depression-focused psychotherapy.",0.75
bupropion benefits patients with low to moderate level of anxiety,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is somewhat related to the ground truth, as both statements discuss treatments for mild to moderate mental health conditions, but the LLM output focuses on anxiety rather than depression.",0.75
cognitive-behavioral therapy (cbt) treats resistant depression,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
Brief explanation: The LLM output captures the essence of CBT for depression but misses the specifics about irrational beliefs and distorted cognitions.",0.75
esketamine definition s-enantiomer of ketamine for treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output mentions a specific drug (esketamine) for treatment-resistant depression rather than the general statement about pharmacotherapy treating the acute phase of depression.",0.75
cognitive-behavioral therapy (cbt) treats elderly depressed patient,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.75
The LLM output is partially correct as it mentioned a type of therapy (CBT) but incorrectly applied it to treating elderly depressed patients instead of patients with personality disorder comorbidity.",0.75
cognitive-behavioral therapy (cbt) treats depression in primary care management,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct, as it correctly identifies cognitive-behavioral therapy as a treatment for depression, but it lacks the specificity of naming the other therapies in the ground truth statement.",0.75
problem-solve therapy (pst) comparable to other psychotherapeutic methods used to treat depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is mostly correct in capturing the essence of problem-solving therapy for depression, but it lacks specificity in terms of the target population (elderly) and primary care setting mentioned in the ground truth.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in children,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct as it correctly identifies cognitive-behavioral therapy as a common treatment for depression, but incorrectly states that it is the first-line treatment for children specifically.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in adolescents,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output contains relevant information about treatment for depression in adolescents, but does not directly address the slower response to treatment as a side effect of depression.",0.75
resistant depression treats vagus nerve stimulation (vns),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct as it correctly identifies vagus nerve stimulation as a treatment for resistant depression, however it fails to mention other somatic treatments and lacks detail.",0.75
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive episode in adult,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct but could be more specific by mentioning that it is depression-focused psychotherapy as the ground truth states.",0.75
vagus nerve stimulation (vns) benefits significant positive outcome observe after six to 12 mo,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.85
The LLM output correctly identifies vagus nerve stimulation (VNS) as a somatic treatment, but there are minor errors in capitalization and missing details about other somatic treatments.",0.85
repetitive transcranial magnetic stimulation (rtms) benefits a well-tolerate profile,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.80
The LLM output is mostly correct, as it mentions repetitive transcranial magnetic stimulation (rTMS) as a somatic treatment, but it does not fully encompass all the treatments listed in the ground truth.",0.8
vagus nerve stimulation (vns) definition a therapeutic method involving the implantation of a pacemaker connected to an electrode surrounding the left vagus nerve,Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.75
The LLM output is mostly on topic by mentioning a treatment for depression, but it inaccurately refers to vagus nerve stimulation instead of electroconvulsive therapy.",0.75
repetitive transcranial magnetic stimulation (rtms) more effective than placebo conditions with mild side effects and good acceptability,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The LLM output is mostly correct but misses some details mentioned in the ground truth, such as the comparison with antidepressants.",0.8
ketamine treats treatment-resistant major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The score is low because the LLM output is completely incorrect in terms of the treatment being discussed.",0.5
esketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is partially correct as esketamine is used to treat treatment-resistant depression, but it does not fully align with the ground truth which refers to pharmacotherapy treating the acute phase of depression in general.",0.75
repetitive transcranial magnetic stimulation example neuro-modulation treatment options for depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is partially correct as it mentions a treatment option for depression but does not directly address the statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is somewhat accurate in mentioning SSRIs as a first-line treatment for major depressive disorder, but it fails to properly address the topic of norepinephrine reuptake inhibitors, therefore lowering its overall correctness score.",0.5
transcranial direct current stimulation (tdcs) used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is partially correct as it mentions a treatment for depressive symptoms in unipolar or bipolar depression patients, but it does not directly address the effects of ketamine on these conditions as stated in the ground truth.",0.75
marital and family therapy (mft) treats some aspects of depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is somewhat correct as marital and family therapy can treat some aspects of depression, but it does not fully capture the specificity of depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
intranasal esketamine form of esketamine,Computerized CBT Is a form of CBT,"Score: 0.50
The LLM output is partially correct as it correctly identifies esketamine in both statements, but misses the additional context provided in the ground truth.",0.5
phototherapy benefits effective for both seasonal and non-seasonal depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.90
The LLM output is mostly correct but lacks the mention of benefits to sleep deprivation and drug treatments reported in the ground truth.",0.9
exercise treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The overall correctness score is low because the LLM output is not accurate and consistent with the ground truth statement.",0.5
psychotherapy treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is not highly correct as it incorrectly states that psychotherapy treats major depressive disorder instead of personality disorder comorbidity, leading to a low score.",0.25
"anxious depression more common than nonanxious depression in african american group, hispanics, primary care patients, unemployed, married then divorced/widowed, less, education, public insurance, lower-income",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is not relevant to the ground truth statement as it focuses on demographic factors related to anxiety and depression, rather than depression-focused psychotherapy being the second most common treatment.",0.5
transcranial direct current stimulation (tdcs) consistency encouraging but vary results that depend on the study’s design and the technique use,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.85
The LLM output is mostly correct but lacks the specificity of the ground truth statement in terms of comparing the results of transcranial direct current stimulation to antidepressants and rTMS.",0.85
vagus nerve stimulation (vns) second-line treatment treatment-resistant major depressive disorder (trd),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct as it mentions VNS as a treatment for major depressive disorder, but it misses the other somatic treatments listed in the ground truth statement.",0.75
cognitive behavioral therapy (cbt) treats major depressive disorder,Group therapy Reduces Depressive Symptoms,"Score: 0.75
The LLM output is partially correct as cognitive behavioral therapy (CBT) is a form of group therapy that is effective in treating major depressive disorder, but it does not specifically mention reducing depressive symptoms.",0.75
"electroconvulsive therapy (ect) highly effective treatment modality for psychiatry, major unipolar depression, and reducing the number of hospital readmissions",Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.90
The LLM output largely captures the main idea of the ground truth, but adds additional information about the efficacy of electroconvulsive therapy for major unipolar depression.",0.9
"electroconvulsive therapy (ect) recommended for patients with severe and psychotic depression, high risk of suicide, parkinson’s disease, and pregnant patients","Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.95
The LLM output is almost identical to the ground truth, with only minor differences in wording and capitalization.",0.95
psychoeducation treats depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is only partially correct as it simplifies the treatment options for depression and does not mention the specific mention of marital and family therapy for severe forms.",0.5
electroconvulsive therapy (ect) treats major depressive disorder (mdd),Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct in identifying a treatment for major depressive disorder, but it does not specifically mention the context of severe depression associated with medications and hospitalization.",0.75
repetitive transcranial magnetic stimulation (rtms) treats major depressive disorder (mdd),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.85
The LLM output is mostly correct but misses some somatic treatments mentioned in the ground truth statement.",0.85
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output provides a list of specific antidepressants, which is partially correct as it mentions escitalopram as the most effective, but misses the mention of rTMS as more effective overall.",0.75
electroconvulsive therapy (ect) definition the most document and effective method in neuro-modulation treatment for depression,"Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.80
The LLM output is mostly correct in describing electroconvulsive therapy as an effective treatment for depression, but it lacks specific eligibility criteria mentioned in the ground truth.",0.8
"mirtazapine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct, but it mentions specific SSRIs which may not be entirely accurate as the ground truth statement did not specify any specific SSRIs.",0.75
reboxetine less effective all tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct but misses the key point that rTMS was found to be more effective than antidepressants in the ground truth statement.",0.75
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies multiple antidepressants as potentially effective, but misses the main point that repetitive transcranial magnetic stimulation (rTMS) is overall more effective.",0.75
major depressive disorder (mdd) definition a mood disorder causing a persistent feeling of sadness and loss of interest,SSRIs Is a part of Pharmacotherapy,"Score: 0.50
The LLM output has some relevance to pharmacotherapy and mood disorders, but is not directly related to SSRIs as the ground truth statement.",0.5
electroconvulsive therapy (ect) associated with reduction in psychiatric readmissions,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is partially correct as it only mentions one treatment option (ECT) out of several listed in the ground truth statement.",0.75
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies venlafaxine as more effective than other antidepressants, but misses the broader comparison with repetitive Transcranial Magnetic Stimulation (rTMS).",0.75
electroconvulsive therapy (ect) side effects cognitive side effects,"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.50
The LLM output only partially captures the side effects mentioned in the Ground Truth, missing important ones like dizziness, neurotoxicity, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms.",0.5
"venlafaxine more effective fluoxetine, fluvoxamine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies venlafaxine as being more effective than fluoxetine and fluvoxamine, but does not explicitly mention rTMS as being more effective overall.",0.75
ketamine associated with risk of misuse and abuse,"Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.75
The score is lower because while the LLM output mentions a risk associated with ketamine, it does not accurately reflect the ground truth about electroconvulsive therapy.",0.75
"escitalopram more effective citalopram, reboxetine, paroxetine, fluoxetine, fluvoxamine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.70
The LLM output correctly identifies different antidepressants but does not accurately reflect the comparison stated in the ground truth.",0.7
"mirtazapine more effective fluoxetine, venlafaxine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output provides some relevant information about the effectiveness of specific antidepressants, but does not fully capture the comparison made in the ground truth statement.",0.75
reboxetine less effective all the other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct as it accurately identifies reboxetine as less effective than the other 11 antidepressants, but it doesn't fully capture the comparison to repetitive Transcranial Magnetic Stimulation (rTMS).",0.75
escitalopram comparable to sertraline,Nefazodone Is comparable to SSRI,"Score: 0.25
The LLM Output incorrectly compares escitalopram and sertraline, which are both SSRIs, rather than comparing Nefazodone to an SSRI.",0.25
escitalopram highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.25
The LLM output is not highly correct as it incorrectly identifies escitalopram as the treatment for major depression, whereas the ground truth discusses electroconvulsive therapy for the acute phase of depression.",0.25
sertraline highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM's output is not highly correct as it inaccurately states that sertraline is highly effective for major depression, which is different from the ground truth about electroconvulsive therapy for acute phase of depression.",0.75
venlafaxine highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output is somewhat relevant as it mentions a type of medication for major depression, but it diverges from the ground truth by not mentioning electroconvulsive therapy and referencing a specific drug instead.",0.5
reboxetine not effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.70
The LLM output is partially correct as it mentions a medication for depression, but it incorrectly states effectiveness and specificity, missing the mention of electroconvulsive therapy.",0.7
sertraline comparable to escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is only partially correct as it mentions two different medications that are comparable, while the ground truth statement specifically mentions Nefazodone and SSRIs.",0.5
mirtazapine highly effective major depression,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output captures the efficacy of mirtazapine for major depression but does not directly compare it to SSRIs as in the Ground Truth.",0.75
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.60

The LLM output correctly identifies sertraline as being more effective than other antidepressants, but it misses the fact that repetitive Transcranial Magnetic Stimulation (rTMS) is also considered more effective.",0.6
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.80
The LLM Output is mostly correct in stating that escitalopram is more effective than other antidepressants, although it lists more options than necessary.",0.8
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output provides a list of specific antidepressants instead of comparing rTMS and antidepressants in general, therefore reducing the overall correctness score.",0.75
"bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine treats unipolar major depression in adults",Pharmacotherapy Treats Acute phase of depression,"Score: 0.85
The LLM output correctly identifies various pharmacological treatments for unipolar major depression in adults, but does not specify that they are used for the acute phase of depression specifically.",0.85
escitalopram benefits balance between efficacy and acceptability,Fluvoxamine Side effects Lower acceptability due to reduced efficacy,"Score: 0.70
The LLM output is partially correct in mentioning the balance between efficacy and acceptability, but it does not directly address the comparison with fluvoxamine side effects.",0.7
repetitive transcranial magnetic stimulation (rtms) comparable to electroconvulsive therapy (ect),"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies repetitive transcranial magnetic stimulation (rTMS) as being comparable to electroconvulsive therapy (ECT) as a somatic therapy option, but does not mention other acute-phase treatment options for depression.",0.75
selective serotonin reuptake inhibitors (ssri) associated with increased risk of sexual dysfunction,Mirtazapine Increases Availability of serotonin or norepinephrine (or both),"Score: 0.75
The LLM output is mostly correct as it mentions the involvement of serotonin but focuses on a different drug class (SSRI) and a different side effect (sexual dysfunction).",0.75
exercise benefits improvement in symptom severity and quality of life in severe mdd,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The statement from the LLM output is somewhat related to the Ground Truth in terms of improving symptoms in depression, but it does not directly address the comparison between Bupropion and SSRIs for symptoms of fatigue and sleepiness.",0.75
sertraline recommended starting treatment for moderate to severe unipolar major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output partially addresses the information in the ground truth by mentioning a specific SSRI (sertraline) for major depression, but does not fully capture the comparison in effectiveness between bupropion and SSRIs.",0.75
venlafaxine comparable to selective serotonin reuptake inhibitors (ssri) and other antidepressants,Nefazodone Is comparable to SSRI,"Score: 0.75
The LLM output is close in meaning but provides additional information about venlafaxine compared to the ground truth.",0.75
anxious depression more common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is only marginally related to the ground truth statement and does not provide an accurate comparison of the two statements.",0.5
citalopram first-line treatment level 1 of star*d for major depressive disorder,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The LLM output is somewhat relevant mentioning first-line treatment for major depressive disorder, but not directly related to cognitive-behavioral therapy as in the ground truth.",0.75
anxious depression definition major depressive disorder with high levels of anxiety symptoms,"Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.75
The LLM output is somewhat related to the ground truth, mentioning major depressive disorder and anxiety symptoms, but it does not accurately capture the eligibility criteria for electroconvulsive therapy.",0.75
"all depression definition a mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life",Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.75
The LLM output provides a general definition of depression but does not specifically address electroconvulsive therapy, reducing its overall correctness.",0.75
bupropion benefits patients with depression requiring an antidepressant with fewer sexual side effects,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is mostly correct as it also mentions the benefits of using bupropion for patients with depression, but it does not fully capture the comparison with SSRIs mentioned in the Ground Truth statement.",0.75
anxious depression associated with poor acute outcome following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct as it mentions depression and poor response to antidepressant treatment, but it adds the element of anxiety which was not present in the ground truth.",0.75
anxious depression more common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is partially incorrect as it misinterprets the ground truth statement.",0.5
nonanxious depression definition major depressive disorder without high levels of anxiety symptoms,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output provides a definition of nonanxious depression which is somewhat related to depression-focused psychotherapy, but doesn't directly address the treatment aspect mentioned in the ground truth.",0.75
electroconvulsive therapy (ect) overview usage in the treatment of major depressive disorder and its potential mechanism,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output covers the general usage and potential mechanism of electroconvulsive therapy for major depressive disorder but does not specifically mention its effectiveness in the acute phase of depression in some situations.",0.75
anxious depression associated with more medical comorbidity,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The output only partially captures the essence of the ground truth statement as it mentions comorbidity but in a different context (medical comorbidity instead of personality disorder comorbidity).",0.5
anxious depression results lower remission rates,Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.75
LLM Output correctly identifies lower remission rates compared to the ground truth, but it does not capture the full extent of the superior performance of transcranial direct current stimulation.",0.75
citalopram treats major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The score is low because the LLM output is not related to the ground truth statement at all.",0.25
sustain-release bupropion second-line treatment nonremitters to citalopram in level 2 of star*d,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.75
The LLM output is somewhat related to the ground truth statement, as it mentions using bupropion as a second-line treatment, hinting at its effectiveness, but does not directly address improving symptoms of fatigue and sleepiness as compared to SSRIs.",0.75
anxious depression associated with serious adverse psychiatric events,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is partially correct as it mentions depression, but it inaccurately states that it is anxious depression associated with serious adverse psychiatric events instead of severe forms of depression associated with medications and hospitalization as in the ground truth.",0.5
anxious depression symptom increased risk of suicidality,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is partially correct as it mentions an aspect of depression (increased risk of suicidality) but does not specifically address the treatment of severe forms of depression associated with medications and hospitalization as stated in the ground truth.",0.75
anxious depression associated with greater overall number of comorbid axis i condition,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is only partially correct as it mentions comorbid conditions, which are related to mental health, but it does not accurately reflect the Ground Truth about problem-solving therapy for preventing and treating depression in the elderly.",0.5
anxious depression associated with greater likelihood of reported suicidal ideation,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is mostly correct in capturing the relationship between depression and suicidal ideation, but it adds the aspect of anxiety which was not present in the ground truth.",0.75
citalopram treats anxious depression symptoms,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is partially correct as citalopram is a medication used to treat depression, but it specifically targets symptoms of anxiety rather than addressing the acute phase of depression.",0.75
anxious depression associated with specific treatment responsivity,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the general concept of depression and treatment responsivity, but does not accurately reflect the idea of a slower response to treatment as stated in the ground truth.",0.75
serotonin and noradrenaline reuptake inhibitors (snri) definition a class of medication used in the treatment of major depressive disorder that inhibits the reuptake of serotonin and noradrenaline,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is mostly correct, but it incorrectly states that SNRIs inhibit the reuptake of serotonin and noradrenaline, when norepinephrine should be mentioned instead of noradrenaline.",0.75
anxious depression associated with poorer treatment outcome with antidepressant monotherapy,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output contains relevant information about depression and treatment outcomes, but the mention of anxiety in the LLM output does not align with the ground truth statement.",0.75
anxious depression less effective antidepressant treatment in achieving remission compared to nonanxious depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.80
The LLM output correctly identifies a comparison between two types of depression and their effectiveness in achieving remission, but lacks specificity to the provided ground truth statement regarding Deep Brain Stimulation findings for treatment-resistant depression.",0.8
"anxious depression associated with higher side effect frequency, intensity, and burden",Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output captures the general idea that depression can be associated with higher side effects, but does not specifically mention slower response to treatment as in the ground truth statement.",0.8
"second-generation antidepressants definition a category of medications for major depressive disorder that includes both selective serotonin reuptake inhibitors (ssris) and serotonin and noradrenaline reuptake inhibitors (snris) among others, known for their improved side effect profile over first-generation antidepressants",Depression Side effect Mortality,"Score: 0.75

The LLM output is mostly correct in terms of explaining the side effects of second-generation antidepressants, but it does not directly address the mortality aspect mentioned in the Ground Truth.",0.75
anxious depression definition a subtype of major depressive disorder with prominent anxiety features,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is relevant to the topic of depression, but it does not accurately reflect the information provided in the ground truth statement.",0.5
anxious depression associated with shorter time in treatment and on the final citalopram dosage,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output accurately identifies the presence of depression and its impact on treatment response, but incorrectly suggests a relationship with anxiety and citalopram dosage.",0.75
"anxious depression side effects greater frequency, intensity, and burden of side effects",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is partially correct as it mentions depression and side effects, but it does not specifically mention suicidal behavior as stated in the ground truth.",0.75
